PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35436937-9	2022	Correspondingly, the expressions of Nrf2, Atm, Atr, and Prkdc in IVM oocytes were markedly increased, following the inhibition of mTORC1 pathway by 10 nM rapamycin.	Sirolimus	154-163	ataxia telangiectasia mutated	Mus musculus	42-45	
20160076-6	2010	Importantly, elevated ROS and dysregulation of mTORC1 in ATM-deficient cells is inhibited by rapamycin, which also rescues lymphomagenesis in Atm-deficient mice.	Sirolimus	93-102	ataxia telangiectasia mutated	Mus musculus	57-60	
20160076-6	2010	Importantly, elevated ROS and dysregulation of mTORC1 in ATM-deficient cells is inhibited by rapamycin, which also rescues lymphomagenesis in Atm-deficient mice.	Sirolimus	93-102	ataxia telangiectasia mutated	Mus musculus	142-145	
19364503-4	2009	Here, we show that inhibition of mTOR signaling with its specific inhibitor, rapamycin, suppresses normal thymocyte DNA synthesis by downregulating 4EBP1, but not S6K, and that 4EBP1 phosphorylation and cyclin D1 expression are coordinately increased in Atm-/- thymocytes.	Sirolimus	77-86	ataxia telangiectasia mutated	Mus musculus	254-257	
19364503-5	2009	Administration of rapamycin to Atm-/- mice attenuates elevated phospho-4EBP1, c-Myc and cyclin D1 in their thymocytes, and delays thymic lymphoma development.	Sirolimus	18-27	ataxia telangiectasia mutated	Mus musculus	31-34